Clinical Trial Update: A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating fecal microbiota transplantation to improve outcomes in liver cirrhosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Snippet

Sponsor: King's College London | Conditions: Liver Cirrhosis | Phase 3 | Status: RECRUITING